These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16643879)

  • 21. Biopsy of cervical lymph node.
    Matsumoto F; Itoh S; Ohba S; Yokoi H; Furukawa M; Ikeda K
    Auris Nasus Larynx; 2009 Feb; 36(1):71-4. PubMed ID: 18479855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of the advantage of determination of urinary pseudouridine for the early detection of a malignant transformation process].
    Senden D; Buchet JP; Lauwerys R
    J Toxicol Clin Exp; 1990; 10(7-8):473-80. PubMed ID: 2135063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circadian variations of interleukin-2 receptors, serum thymidine kinase and beta-2-microglobulin in patients with non-Hodgkin's lymphoma and normal controls.
    Micke O; Schäfer U; Wörmann B; Hiddemann W; Willich N
    Anticancer Res; 1997; 17(4B):3007-10. PubMed ID: 9329587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Excretion patterns of pseudouridine and beta-aminoisobutyric acid in patients with tumours of the upper urinary tract.
    Kvist E; Sjølin KE; Iversen J
    Scand J Urol Nephrol; 1990; 24(4):287-92. PubMed ID: 2274753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of the determination of serum markers in patients with malignant melanoma.
    Lugović L; Situm M; Buljan M; Poduje S; Sebetić K
    Coll Antropol; 2007 Jan; 31 Suppl 1():7-11. PubMed ID: 17469741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Tumor markers in malignant lymphoma].
    Banno S; Ueda R
    Gan To Kagaku Ryoho; 2002 Jan; 29(1):149-53. PubMed ID: 11816473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count.
    Perosa F; Minoia C; Favoino E; Prete M; Dammacco F
    Blood Cells Mol Dis; 2009; 42(1):71-6. PubMed ID: 18996035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum level of intercellular adhesion molecule-1 in children with malignant lymphoma.
    Abdelrazik N; Fouda M; Zaghloul MH; Abbas D
    Med Princ Pract; 2008; 17(3):233-8. PubMed ID: 18408393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum lactate dehydrogenase is a novel marker for the evaluation of disease severity in the early stage of toxic epidermal necrolysis.
    Yun SJ; Choi MS; Piao MS; Lee JB; Kim SJ; Won YH; Lee SC
    Dermatology; 2008; 217(3):254-9. PubMed ID: 18667824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relevance of some serum biomarkers (E cadherin, GAGs & MDA in patients with diffuse large B-cell lymphoma.
    Eissa LA; Esmaeel MI
    Pak J Pharm Sci; 2008 Jan; 21(1):29-35. PubMed ID: 18166516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents].
    Sun XF; Zhen ZJ; Liu DG; Xia Y; Xiang XJ; Chen XQ; Ling JY; Zheng L; Luo WB; Lin H; He YJ; Guan ZZ
    Ai Zheng; 2007 Dec; 26(12):1339-43. PubMed ID: 18076797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CXCL13 and CXCL12 in central nervous system lymphoma patients.
    Fischer L; Korfel A; Pfeiffer S; Kiewe P; Volk HD; Cakiroglu H; Widmann T; Thiel E
    Clin Cancer Res; 2009 Oct; 15(19):5968-73. PubMed ID: 19773382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
    Vidulich KA; Talpur R; Bassett RL; Duvic M
    Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment results of chemoradiation therapy for localized aggressive lymphomas: A retrospective 20-year study.
    Yamashita H; Izutsu K; Nakamura N; Shiraishi K; Chiba S; Kurokawa M; Tago M; Igaki H; Ohtomo K; Nakagawa K
    Ann Hematol; 2006 Aug; 85(8):523-9. PubMed ID: 16691398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
    Mroczko B; Groblewska M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B; Łaszewicz W; Dabrowski A; Szmitkowski M
    Clin Chim Acta; 2007 May; 380(1-2):208-12. PubMed ID: 17368603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiogenic and coagulation-fibrinolysis factors in non Hodgkin's lymphoma.
    Wróbel T; Poreba M; Mazur G; Poreba R; Pyszel A; Beck B; Steinmetz-Beck A; Andrzejak R; Kuliczkowski K
    Neoplasma; 2006; 53(3):253-8. PubMed ID: 16652197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The clinical significance of pseudouridine determination of the urine in children and adolescents].
    Graf N; Bach K; Frisch B; Haas HJ; Sitzmann FC
    Klin Padiatr; 1989; 201(3):154-62. PubMed ID: 2739340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Assay of serum beta 2-microglobulin in patients with malignant hematologic diseases and its clinical significance].
    Zhong M; Liu W
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(3):277-8. PubMed ID: 9868137
    [No Abstract]   [Full Text] [Related]  

  • 39. Relationship of urinary pseudouridine and 1-methyladenosine to activity of leukemia and lymphoma.
    Itoh K; Konno T; Sasaki T; Ishiwata S; Ishida N; Misugaki M
    Clin Chim Acta; 1992 Mar; 206(3):181-9. PubMed ID: 1606704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary excretion of pseudouridine and prognosis of patients with malignant lymphoma.
    Rasmuson T; Björk GR
    Acta Oncol; 1995; 34(1):61-7. PubMed ID: 7865238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.